Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_assertion type Assertion NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_head.
- NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_assertion description "[In contrast, downregulation of clusterin by 2'-O-(2-methoxy)ethyl (2'MOE)-modified antisense oligonucleotides (AS-ODN) directed against clusterin mRNA significantly reduced drug-resistance, i.e., decreased survival of melanoma cells in the presence of cytotoxic drugs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_provenance.
- NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_assertion evidence source_evidence_curated NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_provenance.
- NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_assertion SIO_000772 15955107 NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_provenance.
- NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_assertion wasDerivedFrom ctd_human-20130708 NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_provenance.
- NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_assertion wasGeneratedBy ECO_0000218 NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_provenance.